Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jane Margetts

Newcastle AuthorsTitleYearFull text
Dr Sally Hall
Dr Alastair Greystoke
Dr Christopher Jones
Dr Jane Margetts
Crizotinib in clinical practice: the North East of England's experience2016
Professor Ruth Plummer
Dr Jane Margetts
Professor John Lunec
Dr Joyce Nutt
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker2015
Dr Manolo D'Arcangelo
Dr Jane Margetts
Dr Alastair Greystoke
The use of circulating biomarkers in early clinical trials in patients with cancer2015
Dr Jane Margetts
Dr Yvette Drew
Professor Ruth Plummer
Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors2013
Dr David Jamieson
Kerrie Wilson
Dr Simon Pridgeon
Dr Jane Margetts
Professor Richard Edmondson
et al.
NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism2007
David Talbot
Dr Jane Margetts
Dr Graham Dark
Helen Taylor
Vinflunine (VFL) in first line treatment of malignant pleural mesothelioma (MPM): Final results of a phase II study2005
Dr Andrew Hughes
Dr Ashraf Azzabi
Professor Ruth Plummer
Dr Jane Margetts
Kevin Fishwick
et al.
A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate).2001